French Registry of Acute Coronary Syndrome

Conditions

Acute Myocardial Infarction

Keywords

Coronary syndrome, Myocardial infarction, French registry

Brief summary

The Fast-MI registry was designed to evaluate the real world management of patients with acute myocardial infarction (MI), and to assess their in-hospital, medium and long-term outcomes

Detailed description

Primary objectives : compare survival following the admission to a USIC according to the terms of care

Antoine Fayol, François Schiele, Jean Ferrières, Étienne Puymirat, Vincent Bataille et al. (14 authors)

Circulation Cardiovascular Quality and Outcomes2024-04-298 citations

10.1161/circoutcomes.123.010685

Ventricular fibrillation in acute myocardial infarction: 20-year trends in the FAST-MI study

Rodrigue Garcia, Éloi Marijon, Nicole Karam, Kumar Narayanan, Frédéric Anselme et al. (14 authors)

European Heart Journal2022-10-2830 citations

10.1093/eurheartj/ehac579

Deleterious synergistic effects of acute heart failure and diabetes mellitus in patients with acute coronary syndrome: Data from the FAST-MI Registries.

Dillinger JG, Achkouty G, Albert F, Muller G, Labèque JN, Moisson L, Morelle JF, Cottin Y, Pezel T, Lim P, Aissaoui N, Schiele F, Ferrières J, Angoulvant D, Henry P, Puymirat E, Simon T, Danchin N, FAST-MI investigators.

2022-03-04

10.1016/j.acvd.2022.02.004

The FAST-MI 2005-2010-2015 registries in the light of the COMPASS trial: The COMPASS criteria applied to a post-MI population

François Schiele, Étienne Puymirat, Jean Ferrières, Tabassome Simon, Keith A.A. Fox et al. (7 authors)

International Journal of Cardiology2018-12-0323 citations

10.1016/j.ijcard.2018.11.138

One-Year Survival After ST-Segment–Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy

Nicolas Danchin, Étienne Puymirat, Guillaume Cayla, Yves Cottin, Pierre Coste et al. (14 authors)

Circulation Cardiovascular Interventions2018-09-0118 citations

10.1161/circinterventions.118.007241

β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study

Étienne Puymirat, Elisabeth Riant, Nadia Aissoui, A. Soria, Grégory Ducrocq et al. (17 authors)

BMJ2016-09-20177 citations

10.1136/bmj.i4801

Do randomized clinical trial selection criteria reflect levels of risk as observed in a general population of acute myocardial infarction survivors? The PEGASUS trial in the light of the FAST-MI 2005 registry.

Puymirat E, Schiele F, Zeller M, Jacquemin L, Leclercq F, Marcaggi X, Ferrières J, Simon T, Danchin N, FAST-MI investigators.

2016-08-168 citations

10.1016/j.ijcard.2016.08.191

Editor’s Choice-Medically managed patients with non–ST-elevation acute myocardial infarction have heterogeneous outcomes, based on performance of angiography and extent of coronary artery disease

Laurent J. Feldman, Philippe Gabríel Steg, Myriam Amsallem, Étienne Puymirat, Emmanuel Sorbets et al. (14 authors)

European Heart Journal Acute Cardiovascular Care2016-01-1225 citations

10.1177/2048872615626354

Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme

Étienne Puymirat, Lionel Lamhaut, Nicolas Bonnet, Nadia Aïssaoui, Patrick Henry et al. (15 authors)

European Heart Journal2015-11-1783 citations

10.1093/eurheartj/ehv567

Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry.

Aissaoui N, Puymirat E, Simon T, Bonnefoy-Cudraz E, Angoulvant D, Schiele F, Benamer H, Quandalle P, Prunier F, Durand E, Berard L, Blanchard D, Danchin N.

2014-09-1931 citations

10.1186/s13054-014-0516-y

Five-Year Survival in Patients With ST-Segment–Elevation Myocardial Infarction According to Modalities of Reperfusion Therapy

Nicolas Danchin, Étienne Puymirat, Philippe Gabríel Steg, Patrick Goldstein, François Schiele et al. (12 authors)

Circulation2014-03-22133 citations

10.1161/circulationaha.113.005874

Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction (FAST-MI) Registry

Nadia Aïssaoui, Étienne Puymirat, Tabassome Simon, Eric Bonnefoy‐Cudraz, Denis Angoulvant et al. (13 authors)

Critical Care2014-01-011 citations

10.1186/preaccept-1446656168127984

Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction.

Simon T, Taleb S, Danchin N, Laurans L, Rousseau B, Cattan S, Montely JM, Dubourg O, Tedgui A, Kotti S, Mallat Z.

2012-09-06140 citations

10.1093/eurheartj/ehs263

Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome).

Puymirat E, Taldir G, Aissaoui N, Lemesle G, Lorgis L, Cuisset T, Bourlard P, Maillier B, Ducrocq G, Ferrieres J, Simon T, Danchin N.

2012-09-0159 citations

10.1016/j.jcin.2012.05.008

Genetic determinants of response to clopidogrel and cardiovascular events.

Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L, French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators.

2008-12-221,151 citations

10.1056/nejmoa0808227

Interventions

OTHERBlood sample

60 ml of whole blood

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

* admission within the 48 hours after the occurence of acute myocardial infarction (AMI) * written informed consent for the DNA and serum databank

Exclusion criteria

* AMI occured within the 48 hours after therapeutic intervention (bypass, coronary angioplasty or other chirurgical intervention) * diagnostic of AMI not confirmed

Design outcomes

Primary

Measure	Time frame
All causes mortality at each follow-up period	6 months, each year

Secondary

Measure	Time frame
Cardiovascular mortality	6 month, each year
validation of guidelines across the country	6 month, each year
Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes	6 month each year
Serum databank for evaluation of biomarkers in MI	6 month each year

Countries

France

Outcome results

None listed